Focus

Inspired by the Hon’ble Prime Minister, Shri Narendra Modi’s vision of Atmanirbhar Bharat for the health care sector, with an emphasis on accessibility, affordability, and holistic well-being for citizens across the globe, an integrated event was held that showcased the full spectrum of health care segments. Envisaged as a holistic exhibition, the event brought together diverse sectors, including pharma machinery, pharmaceuticals, medical devices, nutraceuticals, services, and AYUSH.

As a leading stakeholder of the event, EEPC India launched the first editions of two major shows: Pharma Machtech and Labnext Expo 2025, held from 4-6 September 2025 at Bharat Mandapam, New Delhi. These new exhibitions focused on the pharma machinery sector and the laboratory and scientific instruments sector, respectively. The shows aimed to channel resources and enable industry participants to showcase technological developments, cutting-edge machinery, and the latest advancements in pharma manufacturing and diagnostics.

The strategic choice of Bharat Mandapam, New Delhi, was made to encourage maximum participation from domestic and international companies, visitors, policymakers, and academia.

The 2026 edition continues that momentum with a sharper focus on business matchmaking, product discovery, and industry visibility for manufacturers, technology providers, service firms, and innovation-led organisations across the healthcare and scientific sectors.

Why this exhibition matters

By bringing together manufacturers, suppliers, buyers, government stakeholders, and knowledge partners in one place, the event creates a practical marketplace for new business opportunities and long-term industry relationships.

A Glimpse of 2025 edition from Post Show Report

Key Highlights of the 2025 Exhibition

10,000+ Visitors

120 Exhibitors across 6,000 sqm

Curated Buyer-Seller Meets

State Government Participation

500+ Business Enquiries

Co-located with IPHEX

Inauguration of LabNext & PharmaMachTech

Mr Piyush Goyal, Hon’ble Minister of Commerce and Industry, Government of India with EEPC Team comprising

Mr Pradeep Kumar Aggarwal, Regional Chairman (NR), EEPC India

Mr Arun Shukla, Dy Regional Chairman (NR), EEPC India

Mr Adhip Mitra, ED and Secy, EEPC India

Dr Rajat Srivastava, Additional Executive Director, EEPC India

Mr Gurvinder Singh, Sr Director, EEPC India

Mr Asween Mohta, Sr Joint Director, EEPC India

Mr Sudhakaran Nair, Sr Dy Director, EEPC India

EEPC India organized twin shows Pharma MachTech and LabNext Expo at Bharat Mandapam which were held over 4-6 September, 2025 spread over 6,000 sq metres, with over 100 Exhibitors and 25,000 focussed trade visitors. The shows were supported by Ministry of Commerce and Industry, Ministry of MSME, Department of Pharmaceuticals and Central Drugs Standard Control Organisation(CDSCO). IPMMA- Indian Pharma Machinery Manufacturers Association and SIMA Ambala Scientific Instruments Manufacturers’ Association were also supporting associations.

PharmaMachTech focused on pharmaceutical machinery, packaging systems, clean room technologies, process automation, and quality control equipment.

LabNext emphasized analytical instruments, laboratory automation, diagnostics, biotechnology tools, scientific instruments, and research solutions.

Together, the twin expos served as a premier B2B platform for industry leaders, startups, innovators, regulators, and buyers, positioning India as a hub of global pharma and laboratory technology innovation.

Sectoral View Pharmaceutical Machinery: Market Overview

The Indian Pharmaceutical industry is currently ranked third globally in terms of production volume after recording a CAGR of 9.43% in the last nine years. Some of the major segments of the industry include generic drugs, vaccines, contract research & manufacturing, biosimilar, and biologics, etc. India has highest number of pharmaceutical manufacturing facilities that comply with the US Food and Drug Administration (USFDA) and has 500 API producers contributing to around 8% of the worldwide API market. The country is also known as the “Pharmacy of the World” and is expected to reach USD 130 billion by 2030.

Such a vibrant and growing pharmaceutical market has also resulted in the growth and development of a large pharmaceutical machinery industry. As per a 2023 Position Paper by Indian Pharma Machinery Manufacturer’s Association (IPMMA), there are more than 300 companies in India with a total turnover of INR 5000 to 6000 crores.

The industry has been one of the earliest adopters of technology which has increased its demand in the global market. In the current scenario, automation is playing a significant role in the development of the industry. As demand for end-to-end automation increased across the world, Indian manufacturers also integrated automation in data gathering, storing and processing tools for more certainty in real-time decision making. As per the IPMMA Paper, between 2021 and 2030, Pharma automation market size is expected to increase from USD 6.16 billion to USD 12.35 billion. The industry has also witnessed the use of Robots and Collaborative Robots (COBOTS) especially in processing and packaging systems. The industry has also adopted Pharma 4.0 whereby Artificial Intelligence, Machine Learning and Big Data are used to manage research & development and data handling.

Lab Equipment: Lab-equipment or laboratory equipment is one of the key sections of the Indian Pharma machinery industry. It includes machineries used in pharma and medical laboratories and can be broadly classified into:

• Analyser systems/ equipment such as spectrometers, chromatographs, etc.
• Centrifuges
• Drying equipment for the laboratories such as Vacuum ovens, freeze dryers, spray dryers, etc.
• Filtration systems
• Homogenizers
• Microscopes
• Temperature Measurement devices, etc.

Inauguration

The shows were inaugurated by Shri Piyush Goyal, Hon’ble Union Minister for Com- merce and Industry, Government of India. The minister commended EEPC INDIA and other associations for launching new Exhibitions catering to the Pharma Machinery Industry and making the event a totally integrated one.

Some important delegates at the Expo

• Shri Piyush Goyal: Hon’ble Union Minister for Commerce and Industry
• Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI)
• Dr. Rajeev Bahl, secretary, Department of Health Research and director general (DG), Indian Council of Medical Research (ICMR)

4. Shri Nitin Yadav: Additional Secretary- Ministry of Commerce and Industry

5. Shri Vimal Anand, Joint Secretary- Ministry of Commerce and Industry

6. Dr. HG Koshia Gujarat Food and Drug Control Administration (FDCA) Commissioner

7. Shri Pankaj Chadha: Chairman EEPC INDIA

8. Shri Akash Shah, Vice Chairman, EEPC INDIA

9. Shri Namit Joshi: Chairman Pharmexcil

10. Mr Ajit Singh, Chairman, ACG Group

11. Dr Govind Shankar Pandey, CEO & MD, Gamp Technologies Pvt Ltd

12. Arvind Kukrety, Deputy Drugs Controller (India), Central Drugs Standard Control Organization, Government of India

13. Prof. Anand Sharma, Professor, Department of Pharmaceutical Management, National Institute of Pharmaceutical Education & Research (NIPER)

14. Mr Ashwin Haleyur, Partner (Pharma & Lifesciences) at PwC India

15. Mr Arun Shukla, Dy Regional Chairman, Northern Region, EEPC India

16. Ms Sneha Gandhi, Partner, Risk Consulting, PwC India

17. Mr Gagan Kumar, Managing Director - REACHLaw India

18. Mr Robin Banerjee, Vice President, EU Chambers of Commerce and Chairman, Nucleon Research Pvt Ltd

19. Mr Abhay Ranjan, Vice Chairman, International Society for Pharmaceutical Engineering (ISPE)- India Affiliate & CEO HTL BioPharma

20. Mr Rajat Jain, General Manager, Global Sourcing Engineering & Capex, Panacea Biotec

Country-wise Analysis

Trade Scenario of Indian Pharma machinery sector:

Figure 10: Share of Top export destinations for Pharma machinery export in 2025

Observation:

• Figure 10 depicts the top importers of pharma machinery from India in 2025. USA is the top importer from India with a share of 14.6 percent.
• It is followed by UAE, Saudi Arabia, Australia, Germany, Russia, Nigeria, China, Thailand and Mexico – India’s pharma machinery is exported to both developed and developing nations
• Together the top 10 export destinations account for more almost 50 percent of India’s export basket

Source: ITC, Trade map

Figure 11: Share of Top Import Partners in India’s Pharma Machinery Import in 2025

Observation:

• Figure 11 depicts the top exporters of pharma machinery to India in 2025.
• It is followed by Germany, Japan, South Korea and Italy – together they account for more than 70% of India’s import basket.
• China is the top supplier with a share of more than 37 percent in India’s total pharma machinery imports.

Source: ACMA, News Articles

Trade Scenario in the India’s Lab Equipment Sector

Figure: Overall Trade data for India’s Lab Equipment Sector (in USD Bn.)

Observation: The figure depicts India’s overall trade scenario in lab equipment segment during the last 5 years. From the figure it is evident that exports of lab equipment in India have increased during the last 5 years at a CAGR of 5.5%. However, imports during this time also increased by 5.4%. Overall, India has a negative trade balance in this sector.

Source: DGCI&S

Country-wise Analysis

Figure: Share of Top export destinations for Lab Equipment export in 2025

Observation:

• Figure depicts the top importers of labequipment from India during 2025. USA is the top importer from India with a share of 19.3 percent.

• It is followed by Germany, UAE, Saudi Arabia, China, Netherlands & Singapore, etc
• Together the top 10 export destinations account for more almost 58.5 percent of India’s export basket

Source: ITC, Trade map

Country-wise Analysis

Figure: Share of Top Import Partners in India’s Lab Equipment Import in 2025

Observation:

• Figure above depicts the top exporters of lab equipment to India in 2025.
• China is the top supplier with a share of 23.4 percent in India’s total lab equipment imports.
• It is followed by Germany, USA, Singapore and Japan – together they account for almost 70% of India’s import basket

Source: ITC, Trade map

Road Ahead

While the Government’s Make in India initiative is directionally right, its impact on improving access to affordable quality healthcare depends on how it is framed, developed and implemented over the next few months. A ‘step change’ is possible through collaborative transformation, with key levers being suitable policy initiatives, focus on fostering local innovation and making India a global hub for medical device manufacturing

Key Highlights of Pharma Machtech Expo and Labnext Expo 2025